The approval of these projects has come after intensive efforts by India to clarify the bank's misgivings on the utilisation of funds and commitment on having a fully transparent process for procuring drugs that conform to global standards.
The three projects include two in the central sector - Reproductive and Child Health-II Project ($350 million) and National Tuberculosis Control Project-II ($170 million). The third project selected for a $142 million funding is the Karnataka Health Systems Development and Reform Project.
Source: IANS
SRM